Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome–Positive Leukemia | Zendy

Simona Soverini | Zendy; Giovanni Martinelli | Zendy; Sabrina Colarossi | Zendy; Alessandra Gnani | Zendy; Fausto Castagnetti | Zendy; Gianantonio Rosti | Zendy; Costanza Bosi | Zendy; Stefania Paolini | Zendy; Michela Rondoni | Zendy; Pier Paolo Piccaluga | Zendy; Francesca Palandri | Zendy; Panagiota Giannoulia | Zendy; Giulia Marzocchi | Zendy; Simona Luatti | Zendy; Nicoletta Testoni | Zendy; Ilaria Iacobucci | Zendy; Daniela Cilloni | Zendy; Giuseppe Saglio | Zendy; Michele Baccarani | Zendy

Open Access

Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome–Positive Leukemia

Author(s) -

Simona Soverini,

Giovanni Martinelli,

Sabrina Colarossi,

Alessandra Gnani,

Fausto Castagnetti,

Gianantonio Rosti,

Costanza Bosi,

Stefania Paolini,

Michela Rondoni,

Pier Paolo Piccaluga,

Francesca Palandri,

Panagiota Giannoulia,

Giulia Marzocchi,

Simona Luatti,

Nicoletta Testoni,

Ilaria Iacobucci,

Daniela Cilloni,

Giuseppe Saglio,

Michele Baccarani

Publication year - 2006

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2006.08.9128

Subject(s) - dasatinib , medicine , philadelphia chromosome , mutation , abl , cancer research , imatinib , leukemia , acquired resistance , genetics , myeloid leukemia , oncology , chromosomal translocation , cancer , tyrosine kinase , biology , receptor , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research